Smith & Nephew plc
Research Smith & Nephew plc (SNN) on Bullrun: market cap USD 12.43B, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNN
- ExchangeNYSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 12.43B
- Dividend yield2.7%
- Financial periodFY2025
- RevenueUSD 6.16B
- Revenue growth6.1%
- Net incomeUSD 625.00M
- Free cash flowUSD 852.00M
- Gross margin68.0%
Valuation Snapshot
latest market cap is USD 12.43B; dividend yield is 2.7%.
Peer valuation comparison
Latest dividend yield is 2.68% versus a Healthcare sector median of 2.11% (27.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 6.16B | USD 625.00M | USD 852.00M | 68.0% | 1.43 | USD 557.00M | USD 3.33B | USD 5.29B |
| FY2024 | USD 5.81B | USD 412.00M | USD 606.00M | 69.6% | 0.94 | USD 619.00M | USD 3.32B | USD 5.27B |
| FY2023 | USD 5.55B | USD 263.00M | USD 181.00M | 68.8% | 0.6 | USD 302.00M | USD 3.08B | USD 5.22B |
| FY2022 | USD 5.22B | USD 223.00M | USD 110.00M | 70.5% | 0.5 | USD 350.00M | USD 2.87B | USD 5.26B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 12.43B | n/a | 2.7% | 0.78 |
| 2025 | 2025-12-31 | USD 13.93B | n/a | 2.3% | 0.76 |
| 2024 | 2024-12-31 | USD 10.74B | n/a | 3.1% | 0.75 |
| 2023 | 2023-12-29 | USD 11.87B | n/a | 2.7% | 0.75 |
| 2022 | 2022-12-30 | USD 11.68B | n/a | 2.8% | 0.75 |
| 2021 | 2021-12-31 | USD 15.20B | n/a | 2.2% | 0.75 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.78 USD, yield 2.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.76 USD |
| FY2024 | 0.75 USD |
| FY2023 | 0.75 USD |
| FY2022 | 0.75 USD |
| FY2021 | 0.75 USD |
About Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Smith & Nephew plc's market cap?
Smith & Nephew plc's market capitalization is USD 12.43B.
Does Smith & Nephew plc pay a dividend?
Smith & Nephew plc has a dividend yield of 2.7%.
What does Smith & Nephew plc do?
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.